Immune activation, allergic drug toxicity and mortality in HIV-positive tuberculosis

Tubercle and Lung Disease

Volumn 77, Issue 6, 1996, Pages 516-523

  Wallis, R S ^a,c   Helfand, M S ^a   Whalen, C C ^a   Johnson, J L ^a   Mugerwa, R D ^b   Vjecha, M ^a   Okwera, A ^b   Ellner, J J ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b MAKERERE UNIVERSITY   (Uganda)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; NEOPTERIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG HYPERSENSITIVITY; DRUG TOXICITY; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MORTALITY; RANDOMIZED CONTROLLED TRIAL; SKIN TEST; SURVIVAL; UGANDA;

EID: 0030477184     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8479(96)90049-0     Document Type: Article

References (35)

1. Barnes P, Zhang M, Jones B. Modulation of Th1 responses in HIV infection and tuberculosis (TB). Int Conf AIDS 1994; 10: 126.
2. Wallis R S, Vjecha M, Amir Tahmasseb M et al. Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis. J Infect Dis 1993; 167: 43-48.
3. Wallis R S, Amir Tahmasseb M, Ellner J J. Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot. Proc Natl Acad Sci USA 1990; 87: 3348-3352.
4. Kindler V, Sappino A P, Grau G E, Piguet P F, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989; 56: 731-740.
5. Kinter A L, Poli G, Maury W, Folks T M, Fauci A S. Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. J Virol 1990; 64: 4306-4312.
6. Griffin G E, Leung K, Folks T M, Kunkel S, Nabel G J. Induction of NF-kappa B during monocyte differentiation is associated with activation of HIV-gene expression. Res Virol 1991; 142: 233-238.
7. Lederman M M, Georges D L, Kusner D J, Mudido P, Giam C Z, Toossi Z. Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus. J Acquir Immune Defic Syndr 1994; 7: 727-733.
8. Okwera A, Whalen C, Byekwaso F et al. A randomized trial of thiacetazone- and rifampin-containing therapies for pulmonary tuberculosis in HIV-infected Ugandans. Lancet 1994; 344: 1323-1328.
9. Jones B E, Young SMM, Antoniskis D, Davidson P T, Kramer F, Barnes P F. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993; 148: 1292-1297.
10. Falk A, O'Connor J B, Pratt P C, Webb W R, Wier J A, Wolinsky E. Classification of Pulmonary Tuberculosis. In: Anonymous Diagnostic Standards and Classification of Tuberculosis, 12th edn. New York: National Tuberculosis and Respiratory Disease Association, 1969: 68-76.
11. Piwowar E M, Tugume S B, Grant R M, Lutalo T, Pattishall K, Mbidde E K. Beta-2 microglobulin values among HIV-negative, HIV-positive asymptomatic, and HIV-positive symptomatic Ugandans. Clin Diagn Lab Immunol 1995; 2: 236-237.
12. Nsubuga P, Whalen C, Johnson J L et al. Preserved PPD reactivity and frequent cavitary disease as initial clinical manifestations of pulmonary tuberculosis in HIV-infected Ugandans. [Abstract]. Int Conf AIDS 1994; 10.
13. Takashima T, Ueta C, Tsuyuguchi I, Kishimoto S. Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis. Infect Immun 1990; 58: 3286-3292.
14. Barnes P F, Fong S J, Brennan P J, Twomey P E, Mazumder A, Modlin R L. Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol 1990 145: 149-154.
15. Barnes P F, Lu S, Abrams J S, Wang E, Yamamura M, Modlin R L. Cytokine production at the site of disease in human tuberculosis. Infect Immun 1993; 61: 3482-3489.
16. Lantz M, Malik S, Slevin M L, Olsson I. Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine 1990; 2: 402-406.
17. Mohler K M, Torrance D S, Smith C A et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 1993; 151: 1548-1561.
18. Godfried M H, van der Poll T, Weverling G J et al. Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J Infect Dis 1994; 169: 739-745.
19. Schoedon G, Troppmair J, Fontana A, Huber C, Curtius H C, Niederwieser A. Biosynthesis and metabolism of pterins in peripheral blood mononuclear cells and leukemia lines of man and mouse. Eur J Biochem 1987; 166: 303-310.
20. Fahey J L, Taylor J M, Detels R et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990; 322: 166-172.
21. Dolan M J, Lucey D R, Hendrix C W, Melcher G P, Spencer G A, Boswell R N. Early markers of HIV infection and subclinical disease progression. Vaccine 1993; 11: 548-551.
22. Reddy M M, McKinley G F, Grieco M H. Evaluation of HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD4, soluble CD8, and soluble interleukin-2 receptor levels in patients with AIDS or AIDS-related complex treated with 2′,3′ - dideoxyinosine (ddl). J Clin Lab Anal 1991; 5: 396-398.
23. Nunn P, Brindle R, Carpenter L et al. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality. Am Rev Respir Dis 1992; 146: 849-854.
24. Villarino M E, Dooley S W, Geiter L J, Castro K G, Snider D E Jr. Management of persons exposed to multidrug-resistant tuberculosis. Morb Mortal Wkly Rep 1992; 41 (RR-11): 61-71.
25. Whalen C, Horsburgh C R, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995; 151: 129-135.
26. Brindle R J, Nunn P P, Githui W, Allen B W, Gathua S, Waiyaki P. Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis. Am Rev Respir Dis 1993; 147: 958-961.
27. Githui W, Nunn P, Juma E et al. Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results. Tubercle Lung Dis 1992; 73: 203-209.
28. Pape J W, Jean S S, Ho J L, Hafner A, Johnson WDJ. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993; 342: 268-272.
29. Nunn P, Kibuga D, Gathua S et al. Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis. Lancet 1991; 337: 627-630.
30. Perriëns J H, Colebunders R L, Karahunga C et al. Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with 'standard' chemotherapy in Kinshasa, Zaire. Am Rev Respir Dis 1991; 144: 750-755.
31. Okello D O, Sewankambo N, Goodgame R et al. Absence of bacteremia with Mycobacterium avium-intracellulare in Ugandan patients with AIDS. J Infect Dis 1990; 162: 208-210.
32. Pangon B, Michon C, Bizet C et al. [Retrospective bacteriological study of mycobacterial infections in patients with acquired immunodeficiency syndrome]. Presse Med 1988; 17: 945-948.
33. Gilks C F, Brindle R J, Mwachari C et al. Disseminated Mycobacterium avium infection among HIV-infected patients in Kenya. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 195-198.
34. Chan S L, Yew W W, Ma W K et al. The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis. Tubercle Lung Dis 1992; 33-38.
35. Jindani A J, Aber V R, Edwards E A, Mitchison D A. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis 1980; 121: 939-949.